Monro vs Valvoline
MNRO and VVV side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MNRO and VVV compare
Valvoline is the larger company, worth 13 times as much as Monro ($4.4B against $328M).
Valvoline grew revenue faster over the last twelve months (16.1% versus −4.4% for Monro).
Valvoline keeps more of each dollar of sales as profit, with a net margin of 5.2% compared with 0.07% at Monro.
Monro pays a dividend yielding 10.7%; Valvoline does not pay one.
Monro scores higher on the StockData Score (11 against 7 for Valvoline), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MNRO | VVV |
|---|---|---|
| Size and price | ||
| Market cap | $328M | $4.4B |
| Share price | $10.48 | $34.62 |
| Change, 1 year | −42.2% | 8.1% |
| Change, 5 years | −82.6% | −4.0% |
| Beta (5Y) | 0.96 | 0.78 |
| Employees | 6,440 | 11K |
| StockData Score | ||
| Total score | 11 (better) | 7 |
| Valuation score | 4 (better) | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | – | 43.8× |
| P/S | 0.3× (better) | 2.2× |
| P/B | – | 10.6× |
| EV/EBITDA | 5.5× (better) | 19.7× |
| P/FCF | 26.5× (better) | 32.6× |
| FCF yield | 3.8% (better) | 3.1% |
| Fair value | $21.47 | $17.42 |
| Margin of safety | 51.2% (better) | −98.7% |
| Growth | ||
| Revenue growth (TTM) | −4.4% | 16.1% (better) |
| Revenue growth, 5Y average | 0.55% | 18.7% (better) |
| Net income growth (TTM) | – | −63.5% |
| EPS growth (TTM) | – | −63.3% |
| EPS growth, 5Y average | −50.5% | −0.60% (better) |
| Profitability | ||
| Gross margin | 34.8% | 38.3% (better) |
| Operating margin | 1.7% | 15.3% (better) |
| Net margin | 0.07% | 5.2% (better) |
| FCF margin | 1.1% | 6.9% (better) |
| Return on equity | – | 27.8% |
| Return on invested capital | – | 10.9% |
| Financial health | ||
| Debt / equity | – | 3.84 |
| Net debt / EBITDA | 1.49 (better) | 5.04 |
| Current ratio | 0.48 | 0.70 (better) |
| Altman Z-score | 1.29 | 1.81 (better) |
| Piotroski F-score | 5 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 10.7% | – |
| Payout ratio | 4386% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 4.9% | – |
| Buyback yield | – | 0.00% |
| Shareholder yield | 10.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 108% | 117% |
| Held by insiders | 30.7% | 0.33% |
| Insider net buying, 12 months | $502K (better) | −$42.4K |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 32.9% | 11.1% |
Go deeper
- MNRO stock overview
- MNRO income statement
- MNRO valuation and score
- VVV stock overview
- VVV income statement
- VVV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.